Literature DB >> 30190085

Dysfunctional RNA binding proteins and stress granules in multiple sclerosis.

Hannah E Salapa1, Chloe Johnson2, Catherine Hutchinson3, Bogdan F Popescu1, Michael C Levin4.   

Abstract

Dysfunction of the RNA binding protein (RBP) heterogeneous nuclear ribonuclear protein A1 (hnRNP A1) has been shown to contribute to the pathogenesis of neurodegenerative diseases, but its involvement in multiple sclerosis (MS) is largely unknown. In a neuronal cell line, interferon-γ caused hnRNP A1 nucleocytoplasmic mislocalization; colocalization of hnRNP A1 in stress granules (SGs); and inhibition of translation. Neurons in the brain of a MS patient showed pathogenic RBP dysfunction, including nuclear depletion of hnRNP A1, its mislocalization to the cytoplasm, and its colocalization in SGs. These data indicate a role for dysfunctional hnRNP A1 in the pathogenesis of MS.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Heterogeneous nuclear ribonucleoprotein A1; Interferon gamma; Multiple sclerosis; Neurodegeneration; Stress granules; hnRNP A1

Mesh:

Substances:

Year:  2018        PMID: 30190085     DOI: 10.1016/j.jneuroim.2018.08.015

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  13 in total

Review 1.  Physiological, Pathological, and Targetable Membraneless Organelles in Neurons.

Authors:  Veronica H Ryan; Nicolas L Fawzi
Journal:  Trends Neurosci       Date:  2019-09-05       Impact factor: 13.837

Review 2.  The Potential Contribution of Dysfunctional RNA-Binding Proteins to the Pathogenesis of Neurodegeneration in Multiple Sclerosis and Relevant Models.

Authors:  Cole D Libner; Hannah E Salapa; Michael C Levin
Journal:  Int J Mol Sci       Date:  2020-06-27       Impact factor: 5.923

3.  Regulation of zebrafish dorsoventral patterning by phase separation of RNA-binding protein Rbm14.

Authors:  Yue Xiao; Jiehui Chen; Yihan Wan; Qi Gao; Naihe Jing; Yixian Zheng; Xueliang Zhu
Journal:  Cell Discov       Date:  2019-07-23       Impact factor: 10.849

4.  TDP-43 proteinopathy in Theiler's murine encephalomyelitis virus infection.

Authors:  Katsuhisa Masaki; Yoshifumi Sonobe; Ghanashyam Ghadge; Peter Pytel; Raymond P Roos
Journal:  PLoS Pathog       Date:  2019-02-11       Impact factor: 6.823

5.  Natural and pathogenic protein sequence variation affecting prion-like domains within and across human proteomes.

Authors:  Sean M Cascarina; Eric D Ross
Journal:  BMC Genomics       Date:  2020-01-08       Impact factor: 3.969

6.  Neuronal RNA-binding protein dysfunction in multiple sclerosis cortex.

Authors:  Hannah E Salapa; Catherine Hutchinson; Bogdan F Popescu; Michael C Levin
Journal:  Ann Clin Transl Neurol       Date:  2020-07-01       Impact factor: 4.511

7.  Abnormal scaffold attachment factor 1 expression and localization in spinocerebellar ataxias and Huntington's chorea.

Authors:  Nicola Buckner; Kevin C Kemp; Helen L Scott; Gongyu Shi; Caroline Rivers; Andriana Gialeli; Liang-Fong Wong; Oscar Cordero-LLana; Nicholas Allen; Alastair Wilkins; James B Uney
Journal:  Brain Pathol       Date:  2020-07-13       Impact factor: 6.508

8.  Multiple Sclerosis-Associated hnRNPA1 Mutations Alter hnRNPA1 Dynamics and Influence Stress Granule Formation.

Authors:  Joseph-Patrick W E Clarke; Patricia A Thibault; Hannah E Salapa; David E Kim; Catherine Hutchinson; Michael C Levin
Journal:  Int J Mol Sci       Date:  2021-03-12       Impact factor: 5.923

Review 9.  Stress Granules and Neurodegenerative Disorders: A Scoping Review.

Authors:  Mohammad Reza Asadi; Marziyeh Sadat Moslehian; Hani Sabaie; Abbas Jalaiei; Soudeh Ghafouri-Fard; Mohammad Taheri; Maryam Rezazadeh
Journal:  Front Aging Neurosci       Date:  2021-06-23       Impact factor: 5.750

10.  RNA-binding protein altered expression and mislocalization in MS.

Authors:  Katsuhisa Masaki; Yoshifumi Sonobe; Ghanashyam Ghadge; Peter Pytel; Paula Lépine; Florian Pernin; Qiao-Ling Cui; Jack P Antel; Stephanie Zandee; Alexandre Prat; Raymond P Roos
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2020-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.